Last reviewed · How we verify

NCT04773145

Osseointegration of Hydroxyapatite-coated Femoral Stems in Femoral Neck Fractures Over 80 Years

Status unknown Last updated 26 February 2021
What this trial tests

trial testing Hemiarthroplasty with hydroaxyapatite coated stem in Femoral Neck Fractures in 140 participants. Status unknown.

Timeline
24 February 2021
Primary endpoint
24 March 2021
24 March 2021

Quick facts

Lead sponsorCentral Hospital, Nancy, France
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment140
Start date24 February 2021
Primary completion24 March 2021
Estimated completion24 March 2021
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Central Hospital, Nancy, France

Who can join

80 and older, any sex, with Femoral Neck Fractures. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimes to prove that osseointegration of hydroxyapatite coated stem is possible for patients over 80 years with femoral neck fracture, without the risks of cemented stems. The hydroxyapatite has a local effect which can improve cortical index.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Femoral Neck Fractures

Currently open trials in the same condition.

Other Central Hospital, Nancy, France trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04773145.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing